51.   Small-cap biotechnology stocks still have powerful rallying potential, portfolio managers say.

52.   Some U.K. biotechnology stocks, including Cantab Plc and Proteus Plc, have not benefitted from the surge of investment into the sector, he pointed out.

53.   Such failures have soured investors on biotechnology stocks, even those without bad news.

54.   Such is the trouble many investors perceive with biotechnology stocks in general.

55.   The ice-cold market for new biotechnology stocks appears to be warming.

56.   The move is expected to provide a lift to biotechnology stocks.

57.   The Nasdaq composite index cruised to a record Monday, as demand for technology and biotechnology stocks remained strong.

58.   The plunge reminded investors of the risks associated with biotechnology stocks after several companies reported successes in the past two weeks.

59.   The plunge reminded investors of the risks associated with biotechnology stocks after several companies reported successes this week.

60.   The statement inadvertently devastated biotechnology stocks, when it was misinterpreted by the markets as meaning the two governments would oppose patenting human genomic data.